Craven House Capital PLC Change of Company Secretary, Issue of Equity (3303G)

TIDMCRV

RNS Number : 3303G

Craven House Capital PLC

22 July 2019

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

Craven House Capital plc

("Craven House" or the "Company")

Change of Company Secretary, Issue of Equity

Craven House Capital (AIM:CRV) announces the appointment of Ms. Tamra Spink as Company Secretary. Her predecessor, Mr. Brian Winters has stepped down from the role with effect from today.

The Company has allotted 14,400 ordinary shares of $1.00 in the capital of the Company ("Ordinary Shares") at a price of $12.50 per share to Mr. Brian Winters as settlement for company secretarial services provided by him since August 2016.

Application will be made for the admission to trading on AIM ("Admission") for the 14,400 new Ordinary Shares. The new Ordinary Shares will rank pari passu in all respects with the existing Ordinary Shares of the Company. Admission is expected at 8.00 a.m. on or around 26 July 2019.

Total Voting Rights

Following Admission, the Company's issued share capital will comprise 2,513,438 Ordinary Shares which may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules. The Company does not hold any shares in treasury.

Ends

For further information please contact:

 
 Craven House Capital Plc            Tel: 0203 286 8130 
  Mark Pajak 
  www.Cravenhousecapital.com 
 SI Capital                          Tel: 01483 413500 
  Broker 
  Nick Emerson 
  www.sicapital.co.uk 
 
   SPARK Advisory Partners Limited     Tel: 0203 368 3550 
   Nominated Adviser 
   Matt Davis/Mark Brady 
   www.Sparkadvisorypartners.com

About Craven House Capital:

The Company's Investing Policy is to invest in or acquire a portfolio of companies, partnerships, joint ventures, businesses or other assets globally in any geographic jurisdiction. The company will invest in both developed and developing markets providing long term patient capital and is often involved in special situations, restructuring, expansion and turn around investments in crisis and transitioning economies.

 
 1     Details of the person discharging managerial responsibilities/person 
        closely associated 
 a)    Name                                     Mr Brian Winters 
      --------------------------------------  ------------------------------------ 
 2     Reason for the notification 
      ---------------------------------------------------------------------------- 
 a)    Position/status                         Company Secretary 
      --------------------------------------  ------------------------------------ 
 b)    Initial notification                     Initial notification 
        / Amendment 
      --------------------------------------  ------------------------------------ 
 3     Details of the issuer, emission allowance market 
        participant, auction platform, auctioneer or auction 
        monitor 
      ---------------------------------------------------------------------------- 
 a)    Name                                     Craven House Capital Plc 
      --------------------------------------  ------------------------------------ 
 b)    Legal Entity                             2138008MJUBUX6WX9B72 
        Identifier 
      --------------------------------------  ------------------------------------ 
 4     Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type 
        of transaction; (iii) each date; and (iv) each place 
        where transactions have been conducted 
      ---------------------------------------------------------------------------- 
 a)    Description                             Ordinary Shares of $1.00 each 
        of the financial 
        instrument, 
        type of instrument 
                                                GB00BD4FQ360 
        Identification 
        code 
      --------------------------------------  ------------------------------------ 
 b)    Nature of the                           Issue of shares as part of salary 
        transaction 
      --------------------------------------  ------------------------------------ 
 c)    Currency                                GBP 
      --------------------------------------  ------------------------------------ 
 d)    Price(s) and                            Price(s)          Volume(s) 
        volume(s) 
      --------------------------------------  ----------------  ------------------ 
                                               $12.50            14,400 
 -------------------------------------------  ----------------  ------------------ 
 
 e)    Aggregated                               N/A single transaction 
        information 
        - Aggregated 
        volume 
        - Price 
        - Aggregated 
        total 
      --------------------------------------  ------------------------------------ 
 f)    Date of the                              22 July 2019 
        transaction 
      --------------------------------------  ------------------------------------ 
 g)    Place of the                            London Stock Exchange, AIM 
        transaction 
      --------------------------------------  ------------------------------------

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

MSCLLFEEDFIFFIA

(END) Dow Jones Newswires

July 22, 2019 11:56 ET (15:56 GMT)

Craven House Capital (LSE:CRV)
Historical Stock Chart
From Jun 2024 to Jul 2024